Headquartered in Mississauga, Ontario, Diteba is exceptionally well suited to serve as the anchor laboratory for the program, supported by a robust Quality Management System and a multidisciplinary ...

Umbrella Labs today issued a company announcement confirming an internal documentation and traceability update for CJC-1295 ...

Potency assay development uses DoE and QbD to improve accuracy, consistency, and regulatory readiness in biologics testing.

1 MedPharm Manufacturing Services LLC, Durham, USA. 2 Veranova, Devens, USA. 3 Lupin Somerset, Somerset, USA. 4 APPCO Pharma LLC, New Jersey, USA. 5 Dr. Hotha’s ...

This Research Topic is concerned with the exploration of the most recent advancements and developments in the field of pharmaceutical analysis, focusing on non-destructive approaches, predictive ...

Thought LeadersEric MonroeHead, Scientific Library Section, Preservation Research and Testing DivisionThe Library of Congress Eric Monroe shares insights into his role as Head of the Scientific ...

Traditional approaches to analytical method optimization (e.g., univariate and “guess-and-check”) can be time-consuming, costly, and often fail to identify true optima within the parameter space.

A recap of the morning session focused on method development, from Day 2 of HPLC 2025. Method development in LC remains a complex, expertise-heavy process, but emerging AI tools offer new promise for ...

Antibody-drug conjugates (ADCs) are transforming cancer therapy by enabling targeted drug delivery with minimised side effects, but their complex structure presents unique challenges in bioanalysis.

To enhance the efficiency of the analytical method development process, Almac Sciences worked in collaboration with S-Matrix to test the Fusion QbD® software platform. Optimisation of a peptide and ...

Biopharmaceuticals are increasingly utilised in the treatment of oncological, inflammatory, and autoimmune diseases, largely due to their exceptional specificity in targeting antigens. However, their ...